Please use this identifier to cite or link to this item:
http://dspace.mediu.edu.my:8181/xmlui/handle/123456789/4452
Title: | Incomplete Kawasaki disease with recurrent skin peeling: a case report with the review of literature. |
Keywords: | Aspirin therapeutic use Case Report Child Preschool Female Fibrinolytic Agents therapeutic use Human Immunoglobulins Intravenous therapeutic use Mucocutaneous Lymph Node Syndrome classification diagnosis drug therapy Skin Diseases drug therapy etiology |
Issue Date: | 30-May-2013 |
Publisher: | Medknow Publications |
Description: | Kawasaki disease (KD) is an acute systemic vasculitis of unknown aetiology that has largely replaced rheumatic heart disease as a cause of acquired heart disease in children of many developed countries. We report a case of incomplete KD in a five-year-old girl. The diagnosis of incomplete KD was made after exclusion of conditions with similar presentation. She was treated with intravenous immunoglobulin following which she made an uneventful recovery but demonstrated thrombocytosis in the second week of convalescence. During the six-month follow up period, she had two episodes of recurrent skin peeling a phenomenon, which is recently reported with KD but not with atypical or incomplete KD. It is important for the treating physicians to become aware of the incomplete KD as prompt diagnosis and early treatment of these patients with intravenous immunoglobulin is vital for the prevention of lethal coronary complications. Physicians need to have a "high index of suspicion" for KD and even, higher for IKD. |
URI: | http://koha.mediu.edu.my:8181/jspui/handle/123456789/4452 |
Other Identifiers: | http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2003;volume=49;issue=1;spage=72;epage=4;aulast=Parmar http://www.doaj.org/doaj?func=openurl&genre=article&issn=00223859&date=2003&volume=49&issue=1&spage=72 |
Appears in Collections: | Health Sciences |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.